Current Report Filing (8-k)
October 11 2016 - 8:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): October
7, 2016
PhotoMedex, Inc.
(Exact Name of Registrant Specified in Charter)
Nevada
|
0-11635
|
59-2058100
|
(State or Other
|
(Commission File
|
(I.R.S. Employer
|
Jurisdiction of
|
Number)
|
Identification No.)
|
Incorporation)
|
|
|
100 Lakeside Drive, Suite 100, Horsham, Pennsylvania
|
19044
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Registrant’s telephone number, including
area code:
215-619-3600
Not Applicable
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01 Other Events.
On October 7, 2016, Photomedex, Inc. (the
“Company”) (Nasdaq and TASE: PHMD) received written notification (the “Notice”) from The NASDAQ Stock Market
LLC (“NASDAQ”) that the Company has regained compliance with the minimum bid price requirements for continued listing
on Nasdaq’s Capital Stock market. The Company’s common stock had traded at $1.00 per share or greater for the preceding
10 consecutive business days, from September 23 to October 6, 2016.
In the letter, Nasdaq
advised the Company that this matter is now closed.
Forward-Looking Statements
This Current Report on Form 8-K may contain
"forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve
risks and uncertainty. Such statements are based on management's current expectations and are subject to a number of risks and
uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Investors
are cautioned that there can be no assurance actual results or business conditions will not differ materially from those projected
or suggested in such forward-looking statements as a result of various factors. Forward looking statements include, but are not
limited to, statements with respect to the plans, strategies and objectives of management for future operations; product development,
extensions and marketing; and expectations, beliefs or assumptions underlying any of the foregoing. The important factors that
could cause actual results to differ significantly from those expressed or implied by such forward-looking statements include,
but are not limited to, changes in consumers’ spending habits and the marketability of certain products. Please
refer to the risks detailed from time to time in the reports we file with the SEC, including our Annual Report on Form 10-K for
the year ended December 31, 2015, as well as other filings on Form 10-Q and periodic filings on Form 8-K, for additional factors
that could cause actual results to differ materially from those stated or implied by such forward-looking statements. We disclaim
any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future
events, or otherwise, unless required by law.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Company has duly caused this current report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
PHOTOMEDEX, INC.
|
|
|
Date: October 11, 2016
|
By:
|
/s/ Dolev Rafaeli
|
|
|
Dolev Rafaeli
|
|
|
Chief Executive Officer
|
PhotoMedex, Inc. (NASDAQ:PHMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
PhotoMedex, Inc. (NASDAQ:PHMD)
Historical Stock Chart
From Apr 2023 to Apr 2024